SynthesisBlood advances2025

Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis.

Abdulrahman Alhajahjeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.